| Detected | Trial | Change |
|---|---|---|
| 2026-08-09 | NCT02886104 Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous… |
overall status: Recruiting → Unknown |
| 2026-08-08 | NCT06776016 Dietary Supplements to Treat Radiation-Induced Rectal Injury |
date change Primary completion pushed: 2025-09-30 -> 2026-09-30 |
| 2026-08-08 | NCT06776016 Dietary Supplements to Treat Radiation-Induced Rectal Injury |
date change Completion pushed: 2025-12-31 -> 2026-12-31 |
| 2026-08-07 | NCT06510010 Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of… |
Enrollment increased: 180 -> 198 participants |
| 2026-08-05 | NCT06908031 SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer |
Trial completed |
| 2026-08-05 | NCT06908031 SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer |
date change Primary completion moved earlier: 2027-04-01 -> 2026-04-22 |
| 2026-08-05 | NCT06908031 SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer |
date change Completion moved earlier: 2027-04-01 -> 2026-04-22 |
| 2026-08-02 | NCT06652191 Non Dilation on the Central Venous Catheterization（NDCVC-01） |
overall status: Not Yet Recruiting → Unknown |
| 2026-08-02 | NCT04576533 Patients Undergoing Laparoscopic Colorectal Surgery Walk Out From Operating Room After… |
overall status: Recruiting → Unknown |
| 2026-08-01 | NCT07442045 Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib… |
Trial sites expanded: 1 -> 6 locations |
| 2026-08-01 | NCT07442045 Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib… |
date change Primary completion pushed: 2025-09-30 -> 2025-11-30 |
| 2026-08-01 | NCT07442045 Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib… |
date change Completion pushed: 2026-06-01 -> 2026-09-01 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-14 | NCT07765667 NCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06520397 | Efficacy and Safety of Dual-targeted Therapy With Upadacitinib and Ustekinumab Versus… | Crohn Disease | Recruiting |
| NCT07216014 | Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety | Crohn's Disease and Ulcerative Colitis | Recruiting |
| NCT07510191 | TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With… | Crohn Disease (CD) | Recruiting |
| NCT05813860 | HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population… | Crohn Disease | Not Yet Recruiting |
| Phase 3 | |||
| NCT05797077 | Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer… | Colorectal Cancer | Recruiting |
| NCT05815082 | ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer | Colorectal Cancer | Recruiting |
| NCT05797467 | Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal… | Colorectal Cancer | Recruiting |
| NCT06998758 | Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally… | Neoadjuvant Chemotherapy | Recruiting |
| NCT07549399 | SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC | Rectal Adenocarcinoma | Recruiting |
| NCT03975049 | Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for… | Rectal Cancer | Not Yet Recruiting |
| NCT03961841 | Perioperative Combination Chemotherapy Versus Chemoradiation for Locally Advanced EGJ… | Esophagogastric Junction Disorder | Not Yet Recruiting |
| NCT05607927 | PE-Bacon for Late Complications of Chronic Radiation-induced Rectal Injury | Chronic Radiation Injury | Not Yet Recruiting |
| NCT06760065 | Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and… | Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education | Not Yet Recruiting |
| NCT07149467 | Ustekinumab and Upadacitinib for Induction and Maintenance Therapy in Patients With… | Crohn's Disease Aggravated | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT06958419 | Node-Sparing Short-Course Radiotherapy Plus Chemotherapy, Bevacizumab and PD-1 Inhibitor… | Immune Checkpoint Therapy | Recruiting |
| NCT06958432 | Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for… | Rectal Cancer | Recruiting |
| NCT07538284 | MInimizing Delirium With Nasal Dexmedetomidine-InducEd Sleep (MIDDIES) | Major Abdominal Surgery | Not Yet Recruiting |
| Phase 2 | |||
| NCT04989985 | S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric… | Locally Advanced Gastroesophageal Junction Adenocarcinoma | Recruiting |
| NCT06776029 | Fecal Microbiota Transplantation for Radiation-Induced Proctopathy | Radiation Induced Proctitis | Recruiting |
| NCT06923345 | Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for… | Rectal Cancer | Recruiting |
| NCT07230639 | Node-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in… | Neoadjuvant Therapies | Recruiting |
| NCT07279077 | Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in… | Colon Cancer | Recruiting |
| NCT06767007 | SBRT + PD-1 Antibody in Unresectable Locally Recurrent Rectal Cancer（SPARKLE） | Unresectable Locally Recurrent Rectal Cancer | Recruiting |
| NCT07297004 | Stereotactic Body Radiation Therapy for Unresectable Locally Recurrent Rectal Cancer | Unresectable Locally Recurrent Rectal Cancer | Recruiting |
| NCT06002789 | Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC | Multiple Cancer | Recruiting |